March 2011 in “European Urology Supplements” Gene variation affects prostate issues and hair loss.
January 2023 in “International Journal of Clinical and Medical Education Research” This paper discusses prostate cancer diagnosis and treatment controversies and advocates for individualized approaches, reporting no new findings.
This review suggests that finasteride at 1 mg/day reduces PSA levels similarly to 5 mg/day, but differences in prostate dihydrotestosterone levels may affect prostate cancer diagnosis and prevention.
April 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This article discusses the effects of 1mg/day finasteride on PSA levels and its implications for prostate cancer diagnosis, reporting no new clinical results; further investigation is suggested.
March 2011 in “European Urology Supplements” CEC levels may be a useful marker for predicting prostate cancer progression.
